Related Experiment Video

Updated: Jun 3, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

The cost of universal screening for gestational diabetes mellitus in Ireland

P Gillespie1, C O'Neill, G Avalos

  • 1School of Business and Economics, National University of Ireland, Galway, Ireland. paddy.gillespie@nuigalway.ie

Diabetic Medicine : a Journal of the British Diabetic Association
|March 23, 2011
PubMed

Insights

The total healthcare cost for gestational diabetes mellitus screening in Ireland was over €12 million. This study provides crucial data for understanding the economic impact of gestational diabetes and optimizing resource allocation.

Area of Science:

  • Health Economics
  • Public Health
  • Maternal Health

Background:

  • Gestational diabetes mellitus (GDM) poses significant health risks to both mother and child.
  • Effective screening and management strategies are essential for mitigating GDM complications.
  • Estimating the economic burden of GDM is vital for healthcare planning and resource allocation.

Purpose of the Study:

  • To estimate the total healthcare costs associated with universal screening for gestational diabetes mellitus in Ireland.
  • To determine the average cost per case detected and treated for GDM in the Irish healthcare system.

Main Methods:

  • A bottom-up, prevalence-based cost analysis was employed.
  • Healthcare activities were categorized into screening, GDM treatment, prenatal, delivery, and neonatal care.
  • Unit cost data from 2008 were applied to resource utilization, with sensitivity analyses conducted to assess uncertainty.

Main Results:

  • The total estimated healthcare cost for GDM in Ireland was €12,433,320.
  • The average cost per detected case of GDM was €1621.
  • The average total cost per detected and treated case of GDM was €11,903.

Conclusions:

  • This study presents the first comprehensive estimates of healthcare costs for GDM in Ireland.
  • Further research is needed to evaluate the cost-effectiveness of GDM screening programs in the region.
  • Findings can inform future resource allocation decisions for GDM management.
Abstract

More Related Videos

Improving IV Insulin Administration in a Community Hospital12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...